The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
α 2 -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman Primates
Abstract
This study provides evidence that the α 2 -adrenergic receptor agonist clonidine ameliorates the cognitive deficits exhibited by aged nonhuman primates through drug actions at α 2 receptors. Furthermore, pharmacological profiles in animals with lesions restricted to the dorsolateral prefrontal cortex indicate that this area may be the site of action for some of clonidine's beneficial effects. These results demonstrate that α-adrenergic systems contribute to cognitive function and suggest a new strategy for treating memory disorders in aged humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although previous research focused on presynaptic receptor actions, research has established that the beneficial effects of α2-agonists arise from stimulation of postsynaptic α2A-receptors in the PFC (Arnsten and Goldman-Rakic, 1985; Cai et al., 1993).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Goldman-Rakic, 1985
In the citing paper
“Thus, either depletion of noradrenaline52 or blockade of α2A-receptors in the PFC53 impairs working memory, whereas stimulation of postsynaptic α2A-receptors in the PFC improves working memory performance52,56–58.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [52]
In the citing paper
“As shown in FIG. 2, the levels of noradrenaline that are released during alert, non-stressed waking optimize working memory by engaging α2A-receptors52,53, whereas the high levels of noradrenaline that are released during stress impair PFC function by stimulating lower-affinity α1-receptors54 and β1-receptors55.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [52]
In the citing paper
“Either depletion of NE (35) or blockade of α2A receptors in PFC (36) impairs working memory performance in monkeys, suggesting that endogenous NE plays a large role in strengthening working memory performance.”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“Conversely, stimulation of postsynaptic α2A receptors in dorsolateral PFC, e.g., with guanfacine infusions directly into this region, improves working memory performance (35,41–43).”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“Data from studies of monkey dorsolateral PFC demonstrate an inverted-U dose-response: moderate levels of NE released during alert, nonstressed waking improve working memory performance by engaging postsynaptic, α2A receptors (35,36), whereas high levels of NE released during stress impair PFC function via stimulation of lower affinity α1 (37) and β1 receptors (38).”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“In contrast, guanfacine mimics the enhancing effects of norepinephrine at postsynaptic α2A-receptors in the PFC, strengthening network connectivity.”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“The beneficial effects of α2-AR agonists for higher cognitive function were first discovered in aged monkeys (Arnsten et al., 1988, Arnsten and Goldman-Rakic, 1985)”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Arnsten and Goldman-Rakic, 1985
In the citing paper
“early research determined that the beneficial effects of α2-AR agonists on cognition arose from postsynaptic receptor actions in the PFC (Arnsten and Goldman-Rakic, 1985, Cai et al., 1993), with a pharmacological profile consistent with the α2A-AR subtype (Arnsten et al., 1988, Arnsten and Leslie, 1991), a finding later confirmed in genetically altered mice (Franowicz et al., 2002).”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Arnsten and Goldman-Rakic, 1985
In the citing paper
“Early studies discovered that α2-AR agonists markedly improved working memory performance in young monkeys with experimental catecholamine depletion in the dlPFC, with effects consistent with actions at post-synaptic receptors in the dlPFC (Arnsten & Goldman-Rakic, 1985).”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Arnsten & Goldman-Rakic, 1985
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Squire, L. R. (1984) · Springer eBooks · doi:10.1007/978-3-642-70094-1_32 · Cited by 2,130
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
Self-citationAsher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey
Goldman, P. S., & Rosvold, H. E. (1970) · Experimental Neurology · doi:10.1016/0014-4886(70)90222-0 · Cited by 580
Assessment in Geriatric Psychopharmacology
Hynie, S. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90122-x · Cited by 498
Cell loss in the locus coeruleus in senile dementia of Alzheimer type
Tomlinson, B. E., Irving, D., & Blessed, G. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90031-9 · Cited by 453
Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type
Adolfsson, R., Gottfries, C. G., Roos, B. E., & Winblad, B. G. (1979) · The British Journal of Psychiatry · doi:10.1192/bjp.135.3.216 · Cited by 449
Flagged first, then by citations
Research works printed but not linked: 8
- Bartus, R. T., Aging 10: 85 (1979).
- FORNO, L.S., LOCUS CAERULEUS IN ALZHEIMERS-DISEASE, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 37: 614 (1978).
- LOCKHART, M.P., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 10: 995 (1984).
- SLADEK, J.R., AGING 17: 13 (1981).
- WALKER, B, SOCIETY FOR NEUROSCIENCE. ABSTRACTS 10: 64 (1984).
- Wang C. H. Journal of Neuroscience in press.
- WINBLAND, B, AGING 19: 26 (1982).
- Zornetzer, S. F., Neuropsychology of Memory: 588 (1984).
Cited by
Sorted by citations
Items 401–500 of 548
Hassani, S. A., Tiesinga, P. H. E., & Womelsdorf, T. (2024) · Nature Communications · doi:10.1038/s41467-024-54395-8 · Cited by 17
Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia
Kim, S.-W., Cho, T., & Lee, S. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00159 · Cited by 14
Kubo‐Kawai, N., & Kawai, N. (2007) · Journal of comparative psychology · doi:10.1037/0735-7036.121.2.189 · Cited by 14
An open trial of buspirone in the treatment of attention‐deficit disorder
Niederhofer, H. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.511 · Cited by 14
Age-Related Cognitive Deficits and Neurotransmitters
Arnsten, A. F. T. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_5 · Cited by 14
Self-citationMir, F. A., Jha, S. K., & Nehs, C. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106442 · Cited by 17
Torkaman‐Boutorabi, A., Sheidadoust, H., Hashemi-Hezaveh, S.-M., & Zarrindast, M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.03.018 · Cited by 11
Beiranvand, A., Nasehi, M., Zarrindast, M., & Moghaddasi, M. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652585 · Cited by 13
Memory of a drug lapse: Role of noradrenaline
Cummins, E., Boughner, E. N., Kent, K., Kwiatkowski, D., MacDonald, T., & Leri, F. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.020 · Cited by 14
Extract of Ginkgo biloba leaves reverses yohimbine-induced spatial working memory deficit in rats
Zhang, M., & Cai, J. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200512000-00008 · Cited by 13
Tianeptine as a Slightly Effective Therapeutic Option for Attention-Deficit Hyperactivity Disorder
Niederhofer, H. (2004) · Neuropsychobiology · doi:10.1159/000076721 · Cited by 13
Tassin, J., Trovero, F., Hervé, D., Blanc, G., & Glowinski, J. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90243-k · Cited by 13
Sirviö, J., Lukkarinen, K., Riekkinen, P. J., Koivisto, E., Virtanen, R., Pennanen, A. S., Valjakka, A., & Riekkinen, P. J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90068-d · Cited by 13
Sirviö, J., Riekkinen, P. J., MacDonald, E., Airaksinen, M. M., Lammintausta, R. A. S., & Riekkinen, P. J. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251473 · Cited by 13
Chapter 3. Cognition Enhancers
Pavia, M. R., Davis, R. E., & Schwarz, R. D. (1990) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61579-1 · Cited by 13
Ogg, M. C., Lansdell, B., Franks, H. T., Hughes, A. C., Lee, J., Nolen, H. G., Shirinifard, A., & Schwarz, L. A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116687 · Cited by 10
Peripheral endotoxin causes long-lasting changes in locus coeruleus activity via IL-1 in the brain
Borsody, M. K., & Weiss, J. M. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140605.x · Cited by 12
PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice
Betti, A. H., Antonio, C. B., Herzfeldt, V., Pitta, M. G. D. R., Pitta, I. D. R., do Rego, J. L., do-Rego, J.-C., Vaudry, D., & Rates, S. M. K. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000494 · Cited by 12
Continuous intraventricular clonidine infusion in controlled morphine withdrawal – case report
Lorenz, M., Hussein, S., & Verner, L. J. (2002) · Pain · doi:10.1016/s0304-3959(02)00099-4 · Cited by 12
Hartmann, H., Cohen, S. A., & Müller, W. E. G. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90091-g · Cited by 12
Acute Pharmacological Treatment of Schizophrenia
Miyamoto, S., Stroup, T. S., Duncan, G. E., Aoba, A., & Lieberman, J. A. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch24 · Cited by 12
Passive avoidance learning involves α2-noradrenergic receptors in a day old chick
Stamatakis, A., Stewart, M. G., & Dermon, C. R. (1998) · Neuroreport · doi:10.1097/00001756-199806010-00002 · Cited by 12
Hack, L. M., Jubeir, J., Hilton, R. A., Tozzi, L., Boyar, L., Zhang, X., Lyons, T., Jo, B., O'Hara, R. M., Schatzberg, A. F., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00510-7 · Cited by 11
Luo, F., Zheng, J., Sun, X., & Tang, H. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.007 · Cited by 11
Reboreda, A., Theissen, F., Valero-Aracama, M. J., Arboit, A., Corbu, M. A., & Yoshida, M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.042 · Cited by 11
Behandlung kognitiver Defizite bei Schizophrenie
Roesch-Ely, D., Pfueller, U., Mundt, C., Müller, U., & Weisbrod, M. (2010) · Der Nervenarzt · doi:10.1007/s00115-009-2919-6 · Cited by 10
Limbic forebrain toxin trimethyltin reduces behavioral suppression by clonidine
Messing, R. B., Devauges, V., & Sara, S. J. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90532-k · Cited by 11
No association between ADRA2A polymorphisms and schizophrenia
Clark, D. A., Mata, I. F., Kerwin, R. W., Munro, J., & Arranz, M. J. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30355 · Cited by 11
Buccafusco, J. J., Jackson, W. J., & Terry, A. V. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90011-d · Cited by 11
van Herk, L., Schilder, F. P. M., de Weijer, A. D., Bruinsma, B., & Geuze, E. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100659 · Cited by 12
Shade, R. D., Ross, J. A., & Bockstaele, E. J. V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.949361 · Cited by 9
Nido, G. S., Castelli, M., Mostafavi, S., Rubiolo, A., Shadad, O., Alves, G. W., Tysnes, O., Flønes, I. H., Dölle, C., & Tzoulis, C. (2024) · Brain · doi:10.1093/brain/awae355 · Cited by 9
Relationships among cognitive function, fine motor speed and age in the rhesus monkey
Agnès Lacreuse, A., Espinosa, P. M., & Herndon, J. G. (2006) · AGE · doi:10.1007/s11357-006-9019-3 · Cited by 10
Donoyama, N., Satoh, T., Hamano, T., Ohkoshi, N., & Onuki, M. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.06.022 · Cited by 9
Brocos‐Mosquera, I., Gabilondo, A. M., Dı́ez-Alarcia, R., Muguruza, C., Erdozain, A. M., Meana, J. J., & Callado, L. F. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.05.012 · Cited by 9
Methylphenidate does not enhance visual working memory but benefits motivation in macaque monkeys
Oemisch, M., Johnston, K., & Paré, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.019 · Cited by 10
Ma, C., Qi, X.-L., Peng, J., & Li, B. (2003) · Neuroreport · doi:10.1097/00001756-200305230-00021 · Cited by 9
Isometric handgrip exercise speeds working memory responses in younger and older adults.
Bachman, S. L., Attanti, S., & Mather, M. (2023) · Psychology and Aging · doi:10.1037/pag0000728 · Cited by 8
Clinical and Pharmacologic Considerations for Guanfacine Use in Very Young Children
Black, B. T., Soden, S. E., Kearns, G. L., & Jones, B. L. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0159 · Cited by 8
Sex-dependent noradrenergic modulation of premotor cortex during decision-making
Rodberg, E. M., den Hartog, C. R., Dauster, E. S., & Vazey, E. M. (2023) · eLife · doi:10.7554/elife.85590 · Cited by 8
Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug
Walker, R. F., Weideman, C. A., & Wheeldon, E. B. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80068-x · Cited by 8
Luo, F., & Zhou, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14248 · Cited by 8
How should dexmedetomidine and clonidine be prescribed in the critical care setting?
Longrois, D., Petitjeans, F., Simonet, O., Kock, M. D., Bélliveau, M., Pichot, C., Lieutaud, T., GHIGNONE, M., & Quintin, L. (2021) · Critical Care Science · doi:10.5935/0103-507x.20210087 · Cited by 8
Jin, X., Ma, C., & Li, B. (2007) · PubMed · Cited by 8
Cholinergic/Noradrenergic Interactions and Memory
Decker, M. W. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9843-5_5 · Cited by 8
Ahmed, I., & Takeshita, J. (1996) · CNS Drugs · doi:10.2165/00023210-199606010-00005 · Cited by 8
Neurochemistry: Peptides and Alzheimer's disease
Fine, A. (1986) · Nature · doi:10.1038/319537a0 · Cited by 8
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N. C., Lindenberger, U., Kühn, S., & Werkle‐Bergner, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/332098 · Cited by 9
Schneider, J. S. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3330-6_16 · Cited by 8
Childress, A. C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2358987 · Cited by 7
Cognitive Status Changes Based on Time of Day in Nursing Home Patients With and Without Dementia
Madhusoodanan, S., Madhusoodanan, N., Serper, M. R., Sullivan, S. J., D’Antonio, E., Negi, R., & Brenner, R. (2010) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317510372373 · Cited by 7
Serres, F., Rodriguez, M., Rivet, J., Galizzi, J., Lockhart, B. P., Sharp, T., & Millan, M. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.068 · Cited by 7
Sonntag, W. E., Brunso‐Bechtold, J. K., & Riddle, D. R. (2001) · Rejuvenation Research · doi:10.1089/10945450152850641 · Cited by 7
Age-Dependent Performance on Pro-point and Anti-point Tasks
Li, E., Lee, S., Patel, S. S., & Sereno, A. B. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02519 · Cited by 7
Smith, C. P., Brougham, L. R., Huger, F. P., Davis, L., Klein, J. T., & Effland, R. C. (1993) · Drug Development Research · doi:10.1002/ddr.430300402 · Cited by 7
Noradrenergic Effects on Activity of Prefrontal Cortical Neurons in Behaving Monkeys
Sawaguchi, T., & Kikuchi, Y. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60858-3 · Cited by 7
Fletcher, B. R., & Rapp, P. R. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop203024 · Cited by 8
Rupniak, N. M. J., & Iversen, S. D. (1993) · Neuropsychologia · doi:10.1016/0028-3932(93)90037-z · Cited by 7
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.362 · Cited by 6
Self-citationZou, Q., & Wang, J. (2022) · Current Pharmaceutical Analysis · doi:10.2174/1573412918666220614144710 · Cited by 6
Smegal, L. F., Baillet, M., Schneider, C., Jutten, R. J., Boyle, R. T., Rentz, D. M., Johnson, K. A., Sperling, R. A., Papp, K. V., & Jacobs, H. I. L. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.03.015 · Cited by 5
Mirror Neurons, Birdsong, and Human Language: A Hypothesis
Lévy, F. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00078 · Cited by 6
Halperin, J. M., Newcorn, J. H., McKay, K. E., Siever, L. J., & Sharma, V. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322572615 · Cited by 6
Perservative errors in object discrimination learning by aged Japanese monkeys (Macaca fuscata).
Nakamura, K. (2001) · Journal of Experimental Psychology Animal Behavior Processes · doi:10.1037//0097-7403.27.4.345 · Cited by 6
Thierry, A. M., Jay, T. M., Pirot, S., Mantz, J., Godbout, R., & Glowinski, J. (1994) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-85007-3_3 · Cited by 6
Berridge, C. W. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80025-2 · Cited by 6
Exploring the Functional Role of Monoaminergic Neurotransmission
Dolan, R. J., & Grasby, P. M. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.5.575 · Cited by 6
Flügge, G., Brandt, S., & Fuchs, E. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90002-r · Cited by 6
Liefde, I. V., Vauquelin, G., Keyser, J. D., Backer, J. D., & Vos, H. D. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90046-8 · Cited by 6
Dahl, M. J., Bachman, S. L., Dutt, S., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., Werkle‐Bergner, M., & Mather, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.12.511748 · Cited by 6
Nicotine promotes the utility of short-term memory during visual search in macaque monkeys
Sawagashira, R., & Tanaka, M. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06186-6 · Cited by 5
Cox, L. A., Puppala, S., Chan, J., Zimmerman, K. D., Hamid, Z., Ampong, I., Huber, H. F., Li, G., Jadhav, A. Y. L., Wang, B., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.08.009 · Cited by 6
Enhanced Working Memory Representations for Rare Events
Carrasco, C. D., Simmons, A. M., Kiat, J. E., & Luck, S. J. (2025) · Psychophysiology · doi:10.1111/psyp.70038 · Cited by 5
Tanila, H. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90494-e · Cited by 5
Stress, Pharmacology, and Creativity
Beversdorf, D. Q. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316556238.006 · Cited by 4
Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies
Kristiansen, L. V., Cowell, R. M., Biscaia, M., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_14 · Cited by 5
Granholm, A.-C., Helt, C. E., Srivastava, N., Bäckman, C. M., & Gerhardt, G. A. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1142 · Cited by 5
Growth Hormone, Insulin-like Growth Factor- 1, and the Aging Brain
Thornton, P. L., & Sonntag, W. E. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50065-2 · Cited by 5
Chapter 4. Cognitive Disorders
Hershenson, F. M., & Marriott, J. G. (1984) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60680-6 · Cited by 5
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., & Werkle‐Bergner, M. (2019) · MPG.PuRe (Max Planck Society) · Cited by 5
Ontogenetic Development and Decline of Memory Functions in Nonhuman Primates
Bachevalier, J., & Mishkin, M. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6805-2_3 · Cited by 5
Wang, H., Ortega, H. K., Kelly, E. B., Indajang, J., Savalia, N. K., Glaeser-Khan, S., Feng, J., Li, Y., Kaye, A. P., & Kwan, A. C. (2025) · Science Advances · doi:10.1126/sciadv.adr9916 · Cited by 7
Cognitive Enhancers in Exposure Therapy for Anxiety and Related Disorders
Hofmann, S. G., Gutner, C. A., & Asnaani, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3342-2_6 · Cited by 3
The unconscious mental inhibiting process of human maximal voluntary contraction
Takarada, Y., & Nozaki, D. (2021) · Psychological Research · doi:10.1007/s00426-021-01578-3 · Cited by 4
The role of CA1 α-adrenoceptor on scopolamine induced memory impairment in male rats
Azami, N., Piri, M., Jahanshahi, M., Oryan, S., Babapour, V., & Zarrindast, M. R. (2010) · Cited by 4
Pia Rämä, A., Linnankoski, I., & Carlson, S. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00108-1 · Cited by 4
Wang, M., & Arnsten, A. F. T. (2015) · PubMed Central · doi:10.13918/j.issn.2095-8137.2015.6.314 · Cited by 4
Self-citationFuster, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-407815-4.00003-9 · Cited by 4
Alterations in $alpha;-adrenoceptors in aging intraocular hippocampal grafts
JONHAGEN, M. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00053-h · Cited by 4
The Cholinergic Hypothesis a Generation Later
Bartus, R. T. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_1 · Cited by 4
Wei, Y., Jiao, Y., He, X., Tao, X., Li, B., & Zhang, X. (2025) · Biomedicines · doi:10.3390/biomedicines13061322 · Cited by 3
Attention-Deficit and Hyperactivity Disorder: A Disorder or a Fraud?
Chaaya, R., & Khoury, D. E. (2019) · Global Journal of Health Science · doi:10.5539/gjhs.v11n5p100 · Cited by 3
Memory deficits associated with clonidine
Fein, G., Merrin, E. L., Davenport, L., & Buffum, J. C. (1987) · General Hospital Psychiatry · doi:10.1016/0163-8343(87)90029-6 · Cited by 3
CONTRIBUTION OF CATECHOLAMINES TO VISUAL WORKING MEMORY IN THE MACAQUE MONKEY
Oemisch, M. (2012) · QSpace (Queen's University Library) · Cited by 3
Animal Models of Alzheimer’s Disease
Dunnett, S. B. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_14 · Cited by 3
Functional Imaging of Cognitive Psychopharmacology
(2004) · Elsevier eBooks · doi:10.1016/b978-012264841-0/50018-4 · Cited by 3
Neurotransmitter Interactions and Responsivity to Cholinomimetic Agents
Haroutunian, V. H., Santucci, A., & Davis, K. L. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9843-5_8 · Cited by 3
Changes of Hippocampal Noradrenergic Capacity in Stress Condition
Gavrilović, L., Popović, N., Stojiljković, V., Pejić, S., Todorović, A., Pavlović, I., & Pajović, S. B. (2020) · Folia Biologica · doi:10.14712/fb2020066020081 · Cited by 2
Miner, L. A. H., & Sesack, S. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-72256-6_3 · Cited by 2
Can exercise make our children smarter?
Stojiljković, N., Mitić, P. M., & Sporiš, G. (2020) · Annales Kinesiologiae · doi:10.35469/ak.2019.211 · Cited by 2
Metadata
- Authors
- Arnsten, A. F. T., & Goldman-Rakic, P. S.
- Affiliations
- Yale University (US)
- Section of Neuroanatomy, Yale Medical School, New Haven, Connecticut 06510
- ORCID
- Arnsten, Amy F. T.
- Venue
- Science
- Published
- 1985-12-13
- Volume
- 230
- Issue
- 4731
- Pages
- 1273-1276
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000247756
- Cited by
- 549
- References
- 29
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 13 · 2017: 7 · 2016: 11 · 2015: 15 · 2014: 7 · 2013: 14 · 2012: 10
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (NIMH 00298, NIMH-08641, NIMH#38546)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- alpha2-adrenoceptors, clonidine, prefrontal cortex, cognitive decline, aging, non-human primates, memory disorders, adrenergic system, cognitive impairment
- MeSH terms
- Aging, Animals, Cerebral Cortex, Clonidine, Cognition, Female, Hydroxydopamines, Macaca mulatta, Memory, Prazosin, Receptors, Adrenergic, alpha, Yohimbine, Oxidopamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
